Training - ISoP Symposium & Training

ISoP Symposium
& Training for Eurasia

04-05 and 18-19 June 2021
Webinar


The societal importance of pharmacovigilance in Eurasia

ISoP Symposium and Training for Eurasia

Co-ordinator: Jean-Christophe Delumeau (ISoP Executive member).

Organized according to the Plan of Scientific and Practical Events of the Ministry of Healthcare of the Russian Federation, jointly by the Federal Service for Surveillance in Healthcare and the Russian Medical Academy of Continuous Professional Education.

This Symposium and Training was the first of its kind organised by ISoP for Healthcare Professionals involved in ensuring the safe use of medicines in the Eurasian Economic Union (EAEU) and other countries of the Eurasian area. The driving theme of this event was the Societal Importance of Pharmacovigilance in Eurasia and aimed to make all stakeholders better aware of the need to promote the behaviours leading to improved adverse event reporting.

This event was occurring at the crucial time of a significant update of the EAEU Good Vigilance Practices. These practices are designed to prioritise pharmacovigilance activities in proportion to safety risks, implement consistency across National Regulatory Authorities, while utilising advanced analytic methods to safety data.

This event was conducted online on June 4 and 5, then June 18 and 19. Each of those four days was composed of 3 sessions of 90 minutes each with separated by 30-minute intermissions for relaxing. Overall, it provided 12 hours of presentations and 6 hours of panel discussions.

This webinar aimed to engage all interested pharmacovigilance professionals in an industry, regulatory, or university setting.
Training certificates were provided by e-mail to those who complete the training.

The following themes were developed during this Symposium & Training. Presentations were given by speakers from the EAEU or by International Experts member of ISoP or appointed especially. English-Russian and Russian-English simultaneous translation were provided.

June 4 Committing HCPs and the Society to the Importance of Pharmacovigilance
Session 1A The societal importance of pharmacovigilance in Eurasia
Session 1B HCP’s and Patients commitment to the safe use of medicines
Session 1C Improving the Safety Regulatory Framework in Eurasia
June 5 Medical Aspects of Pharmacovigilance
Session 2A Pharmacovigilance of vaccines
Session 2B Medical pharmacovigilance
Session 2C Clinical pharmacovigilance
June 18 Methods in Pharmacovigilance and Risk Minimisation
Session 3A Collecting and managing post-authorisation safety data
Session 3B Detection and management of safety signals
Session 3C Risk minimisation and safety communications methods
June 19 Audits and Inspections
Session 4A Audits and Inspections: Rationale, Principles and legislations
Session 4B Preparing, conducting and experiencing Audits and Inspections
Session 4C Managing Corrective and Preventive Actions (CAPA) followed by Event wrap-up
At the end of this Symposium & Training, participants were expected to have acquired an overall understanding of pharmacovigilance systems, principles, concepts and practices according to internationally agreed standards, and to be capable of promoting those practices in their respective environment.

Programme

Click here for the final programme.

Need more information?

If you would like more details about this webinar or if you have questions about the registration process, please contact ISoP Administration

Registration is now closed.